SEMPRA (SRE) earnings date, results and what the price requires
NYSE · SEC CIK 0001032208 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Mar 31, 2026 | May 7, 2026 | $3.43B | $1.04B | $1.58 | Filing |
| Dec 31, 2025 | Feb 26, 2026 | $3.28B | $352.0M | $0.53 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $2.76B | $95.0M | $0.12 | Filing |
| Jun 30, 2025 | Aug 7, 2025 | $2.70B | $473.0M | $0.71 | Filing |
| Mar 31, 2025 | May 8, 2025 | $3.68B | $917.0M | $1.39 | Filing |
| Dec 31, 2024 | Feb 25, 2025 | $3.07B | $676.0M | $1.04 | Filing |
| Sep 30, 2024 | Nov 6, 2024 | $2.57B | $649.0M | $1.00 | Filing |
| Jun 30, 2024 | Aug 6, 2024 | $2.48B | $725.0M | $1.12 | Filing |
What would SEMPRA have to report for its valuation to change?
At $81.93, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 19.0% a year, to $7.00. On that path the next quarter needs diluted EPS near $0.84, against $0.71 in the quarter ended Jun 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 19.0% | 19.0% |
| EPS needed in final year | $7.00 | $7.00 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. SRE goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.